Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

BACKGROUND: Preclinical and preliminary clinical data indicate that ch14.18, a monoclonal antibody against the tumor-associated disialoganglioside GD2, has activity against neuroblastoma and that such activity is enhanced when ch14.18 is combined with granulocyte–macrophage colony-stimulating factor...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yu, Alice L., Gilman, Andrew L., Ozkaynak, M. Fevzi, London, Wendy B., Kreissman, Susan G., Chen, Helen X., Smith, Malcolm, Anderson, Barry, Villablanca, Judith G., Matthay, Katherine K., Shimada, Hiro, Grupp, Stephan A., Seeger, Robert, Reynolds, C. Patrick, Buxton, Allen, Reisfeld, Ralph A., Gillies, Steven D., Cohn, Susan L., Maris, John M., Sondel, Paul M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2010
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086629/
https://ncbi.nlm.nih.gov/pubmed/20879881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0911123
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak